Terns Pharmaceuticals (TERN) EPS (Weighted Average and Diluted): 2021-2024
Historic EPS (Weighted Average and Diluted) for Terns Pharmaceuticals (TERN) over the last 4 years, with Dec 2024 value amounting to -$1.12.
- Terns Pharmaceuticals' EPS (Weighted Average and Diluted) fell 70.59% to -$0.29 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.27, marking a year-over-year increase of 25.73%. This contributed to the annual value of -$1.12 for FY2024, which is 11.81% up from last year.
- Latest data reveals that Terns Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$1.12 as of FY2024, which was up 11.81% from -$1.27 recorded in FY2023.
- In the past 5 years, Terns Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$1.12 in FY2024 and a low of -$2.21 during FY2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$1.35, with a median of -$1.27 in 2023.
- Data for Terns Pharmaceuticals' EPS (Weighted Average and Diluted) shows a peak YoY climbed of 24.43% (in 2022) over the last 5 years.
- Terns Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.21 in 2021, then climbed by 24.43% to -$1.67 in 2022, then increased by 23.95% to -$1.27 in 2023, then increased by 11.81% to -$1.12 in 2024.